why choose us

First received: July 21, 2022

Clinical Trial: Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections

Study Status: Completed

Recruit Status: RECRUITING

Condition: Recurrent Urinary Tract Infection

Study Type: INTERVENTIONAL


Official Title: Periurethral vs Intravaginal Estrogen for Prevention of Recurrent Urinary Tract Infections: TAPER (Techniques of APplying Vaginal Estrogen for Prevention of Recurrent Urinary Tract Infections) Trial

Brief Summary: Due to rising antibiotic resistance, there has been a focus on non-antibiotic prophylactic measures for postmenopausal patients with recurrent urinary tract infections (rUTI), one of which is the safe and efficacious option of vaginal estrogen therapy.Standard application of vaginal estrogen cream entails intravaginal application of the cream twice a week, but some providers counsel patients with rUTI to apply a small, pea-sized amount to the periurethral area.This ideally reduces the amount of vaginal estrogen…

Read more